Oncopharmpod
Elderly AML & Burkitt Lymphoma Updates
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:24:39
- Mas informaciones
Informações:
Sinopsis
Aggressive hematologic malignancy publications can be challenging to interpret and translate to clinical practice. We look at two recent studies to illustrate this point. Elderly AML: 10-day decitabine vs. 7 + 3 (https://doi.org/10.1016/S2352-3026(23)00273-9) Burkitt Lymphoma: R-CODXO-M/R-IVAC vs. DA-R-EPOCH (https://doi.org/10.1016/S2352-3026(23)00279-X)
